Cover Image
市場調查報告書

主動脈瓣狹窄症 (AS) :主要16市場預測 2015-2025年

Aortic Stenosis Forecast In 16 Major Markets 2015 -2025

出版商 Black Swan Analysis 商品編碼 345870
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
主動脈瓣狹窄症 (AS) :主要16市場預測 2015-2025年 Aortic Stenosis Forecast In 16 Major Markets 2015 -2025
出版日期: 2015年12月01日 內容資訊: 英文 66 Pages
簡介

主動脈瓣狹窄症 (AS) ,是產生主動脈瓣狹窄的主動脈瓣面積的閉塞以及損失。據信現在AS是西歐各國最常見的瓣膜心臟疾病的形態。

本報告提供主要16市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本、土耳其、墨西哥、加拿大、澳洲、芬蘭、波蘭阿根廷及中國) 的主動脈瓣狹窄症的目前患者數 (性別、各年齡世代) 調查分析、目前盛行率,加上疾病概要、危險因素、疾病診斷預後、主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化患者數的手法

  • 追加資料

主動脈瓣狹窄症的盛行率top line

主動脈瓣狹窄症患者的特徵

  • 主動脈瓣狹窄症的重病度
  • 主動脈瓣狹窄症的原因論

主動脈瓣狹窄症的NYHA分類 (心機能力分類)

  • 輕度
  • 重度

重度主動脈瓣狹窄症的症候性 vs. 無症狀性

重度症候性主動脈瓣狹窄症相關的併發症

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文件

附錄

目錄
Product Code: AOST0011115

image1

Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. Currently, AS is thought to be the most common form of valvular heart disease in Western countries. This report provides the current prevalent population for AS across 16 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Turkey, Mexico, Canada, Australia, Finland, Poland, Argentina and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the risk factors, aetiology, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of AS have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Aortic Stenosis include:

  • Previous myocardial infarct / Angina
  • Carotid atherosclerosis
  • COPD
  • Lower limb atherosclerosis
  • Atrial fibrillation
  • Heart failure

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global AS's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of AS and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on AS's prevalent population.
  • Identify sub-populations within AS which require treatment.
  • Gain an understanding of the specific markets that have the largest number of AS patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, PL, TR, CA, AU, AR, MX

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

  • Management of Aortic Valve Stenosis

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

  • Additional data

Top-Line Prevalence for Aortic Stenosis

Features of Aortic Stenosis Patients

  • Severity of Aortic Stenosis
  • Aetiology of Aortic Stenosis

Aortic Stenosis by NYHA Class

  • Moderate Aortic Stenosis by NYHA Class
  • Severe Aortic Stenosis by NYHA Class

Symptomatic vs. Asymptomatic in Severe Aortic Stenosis

Associated Co-morbid Conditions of Severe Symptomatic Aortic Stenosis

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • Classification of Aortic Stenosis severity
  • ESC guidelines for management of Aortic Valve Stenosis
  • ACC/AHA guidelines for management of Aortic Valve Stenosis
  • Prevalence of Aortic Stenosis, total (000s)
  • Prevalence of Aortic Stenosis, males (000s)
  • Prevalence of Aortic Stenosis, females (000s)
  • Severity of stenosis in Aortic Stenosis patients, total (000s)
  • AS patients by main aetiology, total (000s)
  • Moderate AS patients by NYHA Class, total (000s)
  • Severe AS patients by NYHA Class, total (000s)
  • Symptomatic vs. asymptomatic in Severe Aortic Stenosis patients, total (000s)
  • Prevalence of Diabetes in Severe Symptomatic AS patients, total (000s)
  • Prevalence of Dyslipidaemia in Severe Symptomatic AS patients, total (000s)
  • Prevalence of Hypertension in Severe Symptomatic AS patients, total (000s)
  • Prevalence of COPD in Severe Symptomatic AS patients, total (000s)
  • Prevalence of Atrial Fibrillation in Severe Symptomatic AS patients, total (000s)
  • Severe Symptomatic AS patients with a history of MI, total (000s)
  • Prevalence of Carotid Artery Atherosclerosis in Severe Symptomatic AS patients, total (000s)
  • Lower Limb Atherosclerosis in Severe Symptomatic AS patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • USA Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • France Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • France Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Germany Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Italy Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Spain Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Turkey Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Turkey Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Mexico Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Mexico Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Canada Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Canada Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Australia Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Australia Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Finland Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Finland Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Poland Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Poland Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Argentina Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Argentina Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • China Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • China Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
Back to Top